Cell and Gene Logistics
-
Mechanical Cryogenic Freezer
7/3/2025
PHCbi brand's 8.2 cu.ft (231 L) mechanically refrigerated cryogenic freezer uses a reliable, high performance, hybrid cascade refrigeration system designed to achieve cryogenic temperatures of -150°C without requiring LN2. It offers a more economical alternative to liquid nitrogen-based systems and helps reduce the chance of cross-contamination among multiple samples in cryogenic storage. This freezer can store up to 165 2" boxes or 105 3" boxes.
-
Ultra-Low Temperature Chest Freezer With Long-Term Storage
7/3/2025
PHCbi brand's VIP® ECO series -86°C 6.4 cu.ft (180L) ultra-low temperature chest freezer provides reliable, precise temperatures for safe, long-term storage of high-value products. It is designed to fit individual, small group, or clinical uses in a compact footprint. It uses a natural refrigerant, reducing environmental impact without compromising performance. Its sophisticated door latch with magnetic packing seal offers a secure closure of the outer door and helps prevent the loss of cold air.
-
Large Capacity Ultra-Low Temperature Freezer
7/3/2025
PHCbi brand's 29.8 cu.ft (845L) large volume ultra-low temperature freezer delivers reliable temperatures as low as -86°C. This high capacity upright freezer is ideal for use in biorepositories, research freezer farms and facilities where bulk storage of sensitive biological material is managed. Its automatic vacuum relief port equalizes pressure and permits the outer door to be opened easily for quick re-entry.
-
Ultra-Low Temperature Chest Freezer
7/3/2025
PHCbi brand's 12.7 cu.ft (360L) ultra-low temperature freezer features a dual cooling system to offer our highest level of sample protection through the use of two independent refrigeration systems. TwinGuard Series freezers are ideal for safe, long term storage of your most high valued products, such as stem cells, embryos, cell lines, rare specimens, and other biological materials.
-
Dual Cooling System Ultra-Low Temperature Freezer
7/3/2025
PHCbi brand's 25.7 cu.ft (729L) ultra-low temperature TwinGuard freezer features a dual cooling system to offer our highest level of sample protection through the use of two independent refrigeration systems. The combination of these two circuits work together for fast temperature recovery while keeping ultra-low temperatures if one refrigeration system fails to cool. This freezer is ideal for safe, long term storage of your most high valued products, such as stem cells, embryos, cell lines, rare specimens, and other biological materials.
-
Ultra-Low Temperature Freezer With Enhanced Security Features
7/3/2025
PHCbi brand's 18.6 cu.ft (528L) ultra-low temperature freezer offers the flexibility of operating on both 115V or 220V with the switch of a power cord. This model provides enhanced security features and operates at only 4.99kWh per day. SMART features include three lock methods: facial recognition, keypad, or optional proximity card. ENERGY STAR® Certified.
-
Mitigate Frost Buildup With This Ultra-Low Temperature Freezer
7/3/2025
PHCbi brand’s 25.6 cu.ft (725L) FrostLess ultra-low temperature freezer provides reliable temperatures as low as -86°C. It is engineered to mitigate frost buildup more than our category-leading models while maintaining the reliability and energy efficiency that today's laboratories require. It operates on 115V and uses only 7.9kWh per day. ENERGY STAR® Certified.
-
Unlocking The Cold Chain Of Proteins
7/3/2025
Discover how controlled freezing minimizes cryoconcentration and protein denaturation in bulk drug substances. Learn about efficient, scalable freezing solutions for enhanced product stability.
-
Integrated Services: Expertise At Every Step
7/2/2025
Bringing cell and gene therapies to market is complex, but with the right partner, you can overcome challenges and simplify, support, and scale your therapy from development to commercialization.
-
Lab Oversupply Is Pushing Leasing, Rent and Relocation Down
7/1/2025
The landscape of the U.S. pharmaceutical lab market is changing, according to JLL’s U.S. Life Sciences Property Report. In addition to the effort to bring pharma manufacturing back to the U.S. ahead of looming tariffs, an oversupply of space and lower tenant demand in large biopharma markets is dropping leasing rates, rent costs and lease duration, among other changes.